Hanfei Ding

Prof. Dr. Hanfei Ding

Department of Pathology and O’Neal Comprehensive Cancer Center, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294-3300, USA
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2019 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
LWLiyuan Wang
Liyuan Wang
YLYichen Liu
Yichen Liu
TDTingting Du
Tingting Du
HYHeng Yang
Heng Yang
LLLei Lei
Lei Lei
CYChunhong Yan
Chunhong Yan
The amino acid antiporter system Xc− is important for the synthesis of glutathione (GSH) that functions to prevent lipid peroxidation and protect cells from nonapoptotic, iron-dependent death (i.e., ferroptosis). While the activity of system Xc− often positively correlates with the expression level of its light chain encoded by SLC7A11, inhibition of system Xc− activity by small molecules (e.g., erastin) causes a decrease in the intracellular GSH level, leading to ferroptotic cell death. How system Xc− is regulated during ferroptosis remains largely unknown. Here we report that activating transcription factor 3 (ATF3), a common stress sensor, can promote ferroptosis induced by erastin. ATF3 suppressed system Xc−, depleted intracellular GSH, and thereby promoted lipid peroxidation induced by erastin. ATF3 achieved this activity through binding to the SLC7A11 promoter and repressing SLC7A11 expression in a p53-independent manner. These findings thus add ATF3 to a short list of proteins that can regulate system Xc− and promote ferroptosis repressed by this antiporter.

1 June 2002 in Cell
Verified
Journal Article
Closed access
GMGaël G. McGill
Gaël G. McGill
MHMartin Horstmann
Martin Horstmann
HWHans R. Widlund
Hans R. Widlund
JDJinyan Du
Jinyan Du
GMGabriela Motyckova
Gabriela Motyckova
DFDavid E. Fisher
David E. Fisher

28 April 2016 in Autophagy
Verified
Journal Article
Open access
MLMan J. Livingston
Man J. Livingston
Hanfei DingHanfei Ding
Hanfei Ding
SHShuang Huang
Shuang Huang
JHJoseph A. Hill
Joseph A. Hill
XYXiao-Ming Yin
Xiao-Ming Yin
ZDZheng Dong
Zheng Dong
Renal fibrosis is the final, common pathway of end-stage renal disease. Whether and how autophagy contributes to renal fibrosis remains unclear. Here we first detected persistent autophagy in kidney proximal tubules in the renal fibrosis model of unilateral ureteral obstruction (UUO) in mice. UUO-associated fibrosis was suppressed by pharmacological inhibitors of autophagy and also by kidney proximal tubule-specific knockout of autophagy-related 7 (PT-Atg7 KO). Consistently, proliferation and activation of fibroblasts, as indicated by the expression of ACTA2/α-smooth muscle actin and VIM (vimentin), was inhibited in PT-Atg7 KO mice, so was the accumulation of extracellular matrix components including FN1 (fibronectin 1) and collagen fibrils. Tubular atrophy, apoptosis, nephron loss, and interstitial macrophage infiltration were all inhibited in these mice. Moreover, these mice showed a specific suppression of the expression of a profibrotic factor FGF2 (fibroblast growth factor 2). In vitro, TGFB1 (transforming growth factor β 1) induced autophagy, apoptosis, and FN1 accumulation in primary proximal tubular cells. Inhibition of autophagy suppressed FN1 accumulation and apoptosis, while enhancement of autophagy increased TGFB1-induced-cell death. These results suggest that persistent activation of autophagy in kidney proximal tubules promotes renal interstitial fibrosis during UUO. The profibrotic function of autophagy is related to the regulation on tubular cell death, interstitial inflammation, and the production of profibrotic factors.

1 December 2013 in Cell Metabolism
Verified
Journal Article
Closed access
JDJane Ding
Jane Ding
TLTai Li
Tai Li
XWXiangwei Wang
Xiangwei Wang
EZErhu Zhao
Erhu Zhao
JCJeong-Hyeon Choi
Jeong-Hyeon Choi
Hanfei DingHanfei Ding
Hanfei Ding

1 September 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
ZMZhengwei Ma
Zhengwei Ma
LLLin Li
Lin Li
MLMan Livingston
Man Livingston
DZDongshan Zhang
Dongshan Zhang
QMQing-Sheng Mi
Qing-Sheng Mi
ZDZheng Dong
Zheng Dong
Dysregulation of autophagy in diabetic kidney disease (DKD) has been reported, but the underlying mechanism and its pathogenic role remain elusive. We show that autophagy was inhibited in DKD models and in human diabetic kidneys. Ablation of autophagy-related gene 7 (Atg7) from kidney proximal tubules led to autophagy deficiency and worse renal hypertrophy, tubular damage, inflammation, fibrosis, and albuminuria in diabetic mice, indicating a protective role of autophagy in DKD. Autophagy impairment in DKD was associated with the downregulation of unc-51–like autophagy-activating kinase 1 (ULK1), which was mediated by the upregulation of microRNA-214 (miR-214) in diabetic kidney cells and tissues. Ablation of miR-214 from kidney proximal tubules prevented a decrease in ULK1 expression and autophagy impairment in diabetic kidneys, resulting in less renal hypertrophy and albuminuria. Furthermore, blockade of p53 attenuated miR-214 induction in DKD, leading to higher levels of ULK1 and autophagy, accompanied by an amelioration of DKD. Compared with nondiabetic samples, renal biopsies from patients with diabetes showed induction of p53 and miR-214, associated with downregulation of ULK1 and autophagy. We found a positive correlation between p53/miR-214 and renal fibrosis, but a negative correlation between ULK1/LC3 and renal fibrosis in patients with diabetes. Together, these results identify the p53/miR-214/ULK1 axis in autophagy impairment in diabetic kidneys, pinpointing possible therapeutic targets for DKD.

1 July 1998 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
EPE. Roydon Price
E. Roydon Price
Hanfei DingHanfei Ding
Hanfei Ding
TBTina Badalian
Tina Badalian
SBShoumo Bhattacharya
Shoumo Bhattacharya
CTCliff Takemoto
Cliff Takemoto
DFDavid E. Fisher
David E. Fisher
During melanocyte development, the cytokine Steel factor activates its receptor c-Kit, initiating a signal transduction cascade, which is vital for lineage determination via unknown downstream nuclear targets. c-Kit has recently been found to trigger mitogen-activated protein kinase-mediated phosphorylation of Microphthalmia (Mi), a lineage-restricted transcription factor, which, like Steel factor and c-Kit, is essential for melanocyte development. This cascade results in increased Mi-dependent transcriptional reporter activity. Here we examine the mechanism by which Mi is activated by this pathway. Phosphorylation does not significantly alter Mi’s nuclear localization, DNA binding, or dimerization. However, the transcriptional coactivator p300/CBP selectively associates with mitogen-activated protein kinase-phosphorylated Mi, even under conditions in which non-MAPK phospho-Mi is more abundant. Moreover, p300/CBP coactivates Mi transcriptional activity in a manner dependent upon this phosphorylation. Mi thus joins CREB as a transcription factor whose signal-responsive phosphorylation regulates coactivator recruitment, in this case modulating lineage development in melanocytes.